These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 9281610
1. Nucleotide regulation and characteristics of potassium channel opener binding to skeletal muscle membranes. Dickinson KE, Bryson CC, Cohen RB, Rogers L, Green DW, Atwal KS. Mol Pharmacol; 1997 Sep; 52(3):473-81. PubMed ID: 9281610 [Abstract] [Full Text] [Related]
2. Binding of K(ATP) channel modulators in rat cardiac membranes. Löffler-Walz C, Quast U. Br J Pharmacol; 1998 Apr; 123(7):1395-402. PubMed ID: 9579735 [Abstract] [Full Text] [Related]
4. Binding and effects of KATP channel openers in the vascular smooth muscle cell line, A10. Russ U, Metzger F, Kickenweiz E, Hambrock A, Krippeit-Drews P, Quast U. Br J Pharmacol; 1997 Nov; 122(6):1119-26. PubMed ID: 9401776 [Abstract] [Full Text] [Related]
5. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers. Quast U, Bray KM, Andres H, Manley PW, Baumlin Y, Dosogne J. Mol Pharmacol; 1993 Mar; 43(3):474-81. PubMed ID: 8450836 [Abstract] [Full Text] [Related]
7. Mg2+ and ATP dependence of K(ATP) channel modulator binding to the recombinant sulphonylurea receptor, SUR2B. Hambrock A, Löffler-Walz C, Kurachi Y, Quast U. Br J Pharmacol; 1998 Oct; 125(3):577-83. PubMed ID: 9806343 [Abstract] [Full Text] [Related]
8. Binding of [3H]-P1075, an opener of ATP-sensitive K+ channels, to rat glomerular preparations. Metzger F, Quast U. Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):452-9. PubMed ID: 8897448 [Abstract] [Full Text] [Related]
10. Alteration of binding sites for [3H]P1075 and [3H]glibenclamide in renovascular hypertensive rat aorta. He HM, Long CL, Zhang LZ, Fu AL, Wang H. Acta Pharmacol Sin; 2005 Jan; 26(1):69-76. PubMed ID: 15659117 [Abstract] [Full Text] [Related]
11. Interaction between thiol-modifying agents and P1075, a K(ATP) channel opener, in rat isolated aorta. Linde C, Löffler C, Kessler C, Quast U. Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):467-74. PubMed ID: 9349633 [Abstract] [Full Text] [Related]
12. Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits. Löffler-Walz C, Hambrock A, Quast U. Mol Pharmacol; 2002 Feb; 61(2):407-14. PubMed ID: 11809866 [Abstract] [Full Text] [Related]
13. Potentiation of P1075-induced K+ channel opening by stimulation of adenylate cyclase in rat isolated aorta. Linde C, Quast U. Br J Pharmacol; 1995 Jun; 115(3):515-21. PubMed ID: 7582466 [Abstract] [Full Text] [Related]
14. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075. Felsch H, Lange U, Hambrock A, Löffler-Walz C, Russ U, Carroll WA, Gopalakrishnan M, Quast U. Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854 [Abstract] [Full Text] [Related]